Olive supplement and Mediterranean diet for mild memory loss
Part of Mental health clinical trials.
This trial tests whether a dietary supplement made from olive polyphenols, combined with following a Mediterranean diet, can help protect thinking and memory in people with mild cognitive impairment (MCI). It may be a good fit if you have early memory changes and want to try a nutrition-based approach.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 50 and 85 years old.
- You have been diagnosed with mild cognitive impairment (MCI), meaning early memory or thinking changes that are not dementia.
- Your memory test score is in a specific range (MoCA between 18 and 26, or MMSE between 26 and 28).
- You are not currently following a strict diet (like vegan, keto, or weight loss) and have not been for the last 4 weeks.
- You are willing to take an olive-based supplement and follow Mediterranean diet advice.
- You are not taking high doses of fish oil (more than 1 gram per day) or certain other supplements.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a special olive oil supplement, rich in compounds called polyphenols, can improve blood flow and brain function in people with mild memory or thinking problems. Participants will take the supplement and undergo brain scans (MRI) to see if it helps.
This study tests whether a special oil (medium-chain fatty acids) can help people who were recently diagnosed with mild cognitive impairment. If you join, you'll take the oil and be checked to see if it slows down memory decline.
This study tests whether a probiotic (a supplement with helpful bacteria) can help slow down memory and thinking problems in people with mild cognitive impairment (MCI). It is for adults aged 60–85 who have noticed their memory getting worse over time but can still handle daily activities.
This trial tests an oral supplement called gamma glutamylcysteine (GGC) in people with mild cognitive impairment (MCI) to see if it is safe and well-tolerated. It may help by supporting the body's natural defenses against cell damage.
This study tests whether a healthy lifestyle program can help people with mild cognitive impairment (MCI), which is slight memory and thinking decline. It focuses on diet, exercise, and other daily habits to see if they can slow down or improve memory issues.
This study tests an experimental tablet called RP902 for people with mild cognitive impairment (early memory and thinking problems). The goal is to see if it can safely help slow down memory decline.
Hear when a new Mild Cognitive Impairment (MCI) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.